High-dose dexamethasone is a mainstay of therapy for multiple myeloma. However, a study published today online and in the November edition of The Lancet Oncology concludes that lenalidomide plus low-dose dexamethasone is associated with better short-term overall survival and lower toxicity than lenalidomide plus high-dose dexamethasone in patients with newly diagnosed myeloma; and is thus [...]
Journalists: For links to web-video and audio files, see the bottom of this post.
Investigators at the Mayo Clinic Cancer Center have received a five-year, $11.5 million grant to translate research into treatments for women with ovarian cancer. Every year in the United States, more than 16,000 women die from the disease and another 22,000 are [...]
Two Mayo physicians, Veronique L. Roger, M.D., MPH, and Ronald C. Petersen, M.D., Ph.D., recently published editorials in the Journal of American Medicine (JAMA).
Dr. Roger’s editorial, Lifestyle and Cardiovascular Health, discusses that chronic diseases — specifically, cardiovascular diseases — have become the leading cause of death and disability in most countries in the world [...]
A Mayo Clinic project to eliminate wastes from the traditional system of protocol development has reduced turnaround time for clinical trials by 60 percent, as reported online in the June 29 issue of Journal of Clinical Oncology.
The time needed for protocol development shrank from 25 to 10 weeks for internally authored protocols, and 21 weeks [...]
The incidence of a rare and deadly tumor called primary central nervous system lymphoma (PCNSL) is two times higher in black Americans, ages 20 to 49, than in white Americans, according to a Mayo Clinic study published in the June issue of Journal of Neuro-Oncology. In patients older than 49, the results were reversed. White [...]
Dr. Nadia Laack, a Radiation Oncologist, Mayo Clinic-Rochester, was interviewed recently by Australian broadcaster Dr. Norman Swan. The interview, which focused on treating brain tumors, including surgery and radiation therapy, is available here: http://www.abc.net.au/rn/healthreport/stories/2009/2609586.htm.
Diffusion tensor MR imaging (DTI) provides information on the tissue microstructure in the brain. The data generated by this imaging technology may be helpful in differentiating between various forms of dementias and cognitive impairment in the future.
One study looked at the DTI characteristics of patients with dementia with Lewy bodies compared to patients with Alzheimer’s [...]
A new Mayo Clinic study found that the clinical criteria for mild cognitive impairment is better at predicting who will develop Alzheimer’s disease than a single memory test. This is one more piece of information to aid in the identification and early treatment of individuals most likely to develop Alzheimer’s disease. The study was presented [...]
Dr. Ron Petersen, Director of the Mayo Clinic’s Alzheimer’s Disease Research Center, and Dr. Claudia Kawas, Neurologist at the University of California, Irvine, recently appeared on Minnesota Public Radio’s Midmorninng program. Here is a link to the program: The 90+ study, Alzheimer’s and aging.
|
